HIGH COUNTRY VENTURE
The Colorado Fund is a venture capital fund seeking to invest in seed and early stage businesses in Colorado. The fund will focus its investments in Life Sciences (including biotechnology, clean technology, and medical devices), information technology (including software and Internet companies) and retail. They encourage all qualified businesses in rural areas who are seeking capital to submit a business plan, regardless of the industry you are in.
HIGH COUNTRY VENTURE
Social Links:
Industry:
Venture Capital
Founded:
2005-01-01
Status:
Active
Contact:
(303) 381-2638
Email Addresses:
[email protected]
Technology used in webpage:
Apache Google Apps For Business Google Maps Google Maps Embed
Similar Organizations
Arenberg Holdings
A venture fund seeking to invest capital and expertise in early stage midwestern companies.
True Ventures
True Ventures is a venture capital firm that invests in early-stage technology startups.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-04-14 | Covalent Data | High Country Venture investment in Series A - Covalent Data | 1.2 M USD |
2015-12-02 | TriSalus Life Sciences | High Country Venture investment in Series C - TriSalus Life Sciences | 15.05 M USD |
2015-05-12 | Kapost | High Country Venture investment in Venture Round - Kapost | 10.25 M USD |
2015-05-07 | Documoto | High Country Venture investment in Series B - Documoto | 9 M USD |
2015-04-20 | Nutrinsic | High Country Venture investment in Venture Round - Nutrinsic | 1.61 M USD |
2014-08-14 | Nutrinsic | High Country Venture investment in Series C - Nutrinsic | 12.7 M USD |
2013-12-18 | Nutrinsic | High Country Venture investment in Series B - Nutrinsic | 12.7 M USD |
2013-11-21 | Collective IP | High Country Venture investment in Series A - Collective IP | 2.5 M USD |
2013-11-20 | Covalent Data | High Country Venture investment in Series A - Covalent Data | 2.5 M USD |
2013-11-07 | TriSalus Life Sciences | High Country Venture investment in Series B - TriSalus Life Sciences | 18.2 M USD |